cyclin dependent kinase 13 | CRK7 subfamily | IUPHAR/BPS Guide to PHARMACOLOGY

Top ▲

cyclin dependent kinase 13

Target not currently curated in GtoImmuPdb

Target id: 1966

Nomenclature: cyclin dependent kinase 13

Abbreviated Name: CDK13

Family: CRK7 subfamily

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 1512 7p14.1 CDK13 cyclin dependent kinase 13
Mouse - 1511 13 A3.1 Cdk13 cyclin-dependent kinase 13
Rat - 1511 17 q12.1 Cdk13 cyclin-dependent kinase 13
Previous and Unofficial Names
CDC2L | CDC2L5 | CDC2-related protein kinase 5 | cell division cycle 2-like 5 | cell division protein kinase 13
Database Links
ChEMBL Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Enzyme
RefSeq Nucleotide
RefSeq Protein
Enzyme Reaction
EC Number:
EC Number:

Download all structure-activity data for this target as a CSV file

Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
CDK12 inhibitor 2 Hs Inhibition 8.0 pIC50 2
pIC50 8.0 (IC50 1x10-8 M) [2]
DiscoveRx KINOMEscan® screen
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
Reference: 1,3

Key to terms and symbols Click column headers to sort
Target used in screen: CDC2L5
Ligand Sp. Type Action Value Parameter
AST-487 Hs Inhibitor Inhibition 9.0 pKd
AT-7519 Hs Inhibitor Inhibition 8.5 pKd
BMS-387032 Hs Inhibitor Inhibition 7.6 pKd
linifanib Hs Inhibitor Inhibition 7.4 pKd
staurosporine Hs Inhibitor Inhibition 7.2 pKd
R547 Hs Inhibitor Inhibition 7.0 pKd
foretinib Hs Inhibitor Inhibition 6.7 pKd
alvocidib Hs Inhibitor Inhibition 6.4 pKd
BMS-345541 Hs Inhibitor Inhibition 6.1 pKd
lestaurtinib Hs Inhibitor Inhibition 6.0 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »
Immuno Process Associations
Immuno Process:  Inflammation
GO Annotations:  Associated to 1 GO processes
GO:0043312 neutrophil degranulation TAS
Immuno Process:  Immune system development
GO Annotations:  Associated to 1 GO processes
GO:0030097 hemopoiesis IMP
Immuno Process:  Cellular signalling
GO Annotations:  Associated to 1 GO processes
GO:0043312 neutrophil degranulation TAS


Show »

1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol., 29 (11): 1046-51. [PMID:22037378]

2. Ito M, Tanaka T, Toita A, Uchiyama N, Kokubo H, Morishita N, Klein MG, Zou H, Murakami M, Kondo M et al.. (2018) Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors. J. Med. Chem., 61 (17): 7710-7728. [PMID:30067358]

3. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem. Biol., 17 (11): 1241-9. [PMID:21095574]

How to cite this page

CRK7 subfamily: cyclin dependent kinase 13. Last modified on 28/08/2018. Accessed on 23/09/2020. IUPHAR/BPS Guide to PHARMACOLOGY,